These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34275910)

  • 1. Clinical and Dopamine Depletion Patterns in Hyposmia- and Dysautonomia-Dominant Parkinson's Disease.
    Yoo HS; Lee S; Jeong SH; Ye BS; Sohn YH; Yun M; Lee PH
    J Parkinsons Dis; 2021; 11(4):1703-1713. PubMed ID: 34275910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease with hyposmia and dysautonomia: does it represent a distinct subtype?
    Yoon SH; You DH; Na HK; Kang S; Baik K; Park M; Lyoo CH; Sohn YH; Lee PH
    J Neurol; 2024 Aug; 271(8):5064-5073. PubMed ID: 38806701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.
    Kang SH; Lee HM; Seo WK; Kim JH; Koh SB
    J Neurol Sci; 2016 Sep; 368():374-8. PubMed ID: 27538667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease.
    Shin HW; Chung SJ; Lee S; Cha J; Sohn YH; Yun M; Lee PH
    Clin Nucl Med; 2020 Aug; 45(8):e342-e348. PubMed ID: 32520498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition and Other Non-Motor Symptoms in an At-Risk Cohort for Parkinson's Disease Defined by REM-Sleep Behavior Disorder and Hyposmia.
    Pauly L; Rauschenberger A; Pauly C; Schröder VE; Van Cutsem G; Leist AK; Krüger R;
    J Parkinsons Dis; 2024; 14(3):545-556. PubMed ID: 38669560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
    Hinkle JT; Perepezko K; Mills KA; Mari Z; Butala A; Dawson TM; Pantelyat A; Rosenthal LS; Pontone GM
    Parkinsonism Relat Disord; 2018 Oct; 55():8-14. PubMed ID: 30146185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.
    Mao CJ; Wang F; Chen JP; Yang YP; Chen J; Huang JY; Liu CF
    Clin Interv Aging; 2017; 12():1637-1644. PubMed ID: 29070942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity.
    Bohnen NI; Gedela S; Herath P; Constantine GM; Moore RY
    Neurosci Lett; 2008 Dec; 447(1):12-6. PubMed ID: 18838108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.
    Roos DS; Twisk JWR; Raijmakers PGHM; Doty RL; Berendse HW
    J Neural Transm (Vienna); 2019 Nov; 126(11):1471-1478. PubMed ID: 31515655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease.
    Mizutani Y; Nakamura T; Okada A; Suzuki J; Watanabe H; Hirayama M; Sobue G
    Parkinsonism Relat Disord; 2014 May; 20(5):520-4. PubMed ID: 24637128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study.
    Tambasco N; Mechelli A; Nigro P; Simoni S; Paolini Paoletti F; Eusebi P; Brahimi E; Maremmani C; Parnetti L
    Neurol Sci; 2024 Aug; 45(8):3791-3798. PubMed ID: 38499888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REM sleep behavior disorder correlates with constipation in de novo Chinese Parkinson's disease patients.
    Chen Y; Xu Q; Wu L; Zhou M; Lin Y; Jiang Y; He Q; Zhao L; Dong Y; Liu J; Chen W
    Neurol Sci; 2023 Jan; 44(1):191-197. PubMed ID: 36098886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.
    Chahine LM; Weintraub D; Hawkins KA; Siderowf A; Eberly S; Oakes D; Seibyl J; Stern MB; Marek K; Jennings D;
    Mov Disord; 2016 Jan; 31(1):86-94. PubMed ID: 26293177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease.
    Oka H; Toyoda C; Yogo M; Mochio S
    J Neurol; 2010 Jun; 257(6):969-76. PubMed ID: 20119648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease.
    Oh YS; Kim JS; Hwang EJ; Lyoo CH
    Parkinsonism Relat Disord; 2018 Nov; 56():47-51. PubMed ID: 29925486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.
    Bohnen NI; Gedela S; Kuwabara H; Constantine GM; Mathis CA; Studenski SA; Moore RY
    J Neurol; 2007 Jan; 254(1):84-90. PubMed ID: 17508142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder.
    Aguirre-Mardones C; Iranzo A; Vilas D; Serradell M; Gaig C; Santamaría J; Tolosa E
    J Neurol; 2015 Jun; 262(6):1568-78. PubMed ID: 25929658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's disease.
    Miller-Patterson C; Hsu JY; Chahine LM; Morley JF; Willis AW
    Clin Auton Res; 2022 Dec; 32(6):463-476. PubMed ID: 36057046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.